357 related articles for article (PubMed ID: 17085122)
1. Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings.
Villers A; Puech P; Mouton D; Leroy X; Ballereau C; Lemaitre L
J Urol; 2006 Dec; 176(6 Pt 1):2432-7. PubMed ID: 17085122
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
3. Dynamic contrast-enhanced-magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimens.
Puech P; Potiron E; Lemaitre L; Leroy X; Haber GP; Crouzet S; Kamoi K; Villers A
Urology; 2009 Nov; 74(5):1094-9. PubMed ID: 19773038
[TBL] [Abstract][Full Text] [Related]
4. Phased array magnetic resonance imaging for staging clinically localised prostrate cancer.
Borre M; Lundorf E; Marcussen N; Langkilde NC; Wolf H
Acta Oncol; 2005; 44(6):589-92. PubMed ID: 16294442
[TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy.
Haider MA; Chung P; Sweet J; Toi A; Jhaveri K; Ménard C; Warde P; Trachtenberg J; Lockwood G; Milosevic M
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):425-30. PubMed ID: 17881141
[TBL] [Abstract][Full Text] [Related]
6. [Quantitative dynamic MRI and localisation of non-palpable prostate cancer].
Cornud F; Beuvon F; Thévenin F; Chauveinc L; Vieillefond A; Descazeaux A; Flam T
Prog Urol; 2009 Jun; 19(6):401-13. PubMed ID: 19467459
[TBL] [Abstract][Full Text] [Related]
7. Value of magnetic resonance spectroscopy imaging and dynamic contrast-enhanced imaging for detecting prostate cancer foci in men with prior negative biopsy.
Sciarra A; Panebianco V; Ciccariello M; Salciccia S; Cattarino S; Lisi D; Gentilucci A; Alfarone A; Bernardo S; Passariello R; Gentile V
Clin Cancer Res; 2010 Mar; 16(6):1875-83. PubMed ID: 20197480
[TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted magnetic resonance imaging in patients with unilateral prostate cancer on extended prostate biopsy: predictive accuracy of laterality and implications for hemi-ablative therapy.
Jeong IG; Kim JK; Cho KS; You D; Song C; Hong JH; Ahn H; Kim CS
J Urol; 2010 Nov; 184(5):1963-9. PubMed ID: 20851437
[TBL] [Abstract][Full Text] [Related]
9. [Endorectal magnetic resonance imaging for staging of prostatic cancer].
Hayashi N; Kawamura J; Sugimura Y
Hinyokika Kiyo; 1996 Oct; 42(10):767-73. PubMed ID: 8951473
[TBL] [Abstract][Full Text] [Related]
10. Endorectal MRI for prediction of tumor site, tumor size, and local extension of prostate cancer.
Nakashima J; Tanimoto A; Imai Y; Mukai M; Horiguchi Y; Nakagawa K; Oya M; Ohigashi T; Marumo K; Murai M
Urology; 2004 Jul; 64(1):101-5. PubMed ID: 15245944
[TBL] [Abstract][Full Text] [Related]
11. Wash-in rate on the basis of dynamic contrast-enhanced MRI: usefulness for prostate cancer detection and localization.
Kim JK; Hong SS; Choi YJ; Park SH; Ahn H; Kim CS; Cho KS
J Magn Reson Imaging; 2005 Nov; 22(5):639-46. PubMed ID: 16200542
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of normal prostate tissue, chronic prostatitis, and prostate cancer by quantitative perfusion analysis using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence.
Franiel T; Lüdemann L; Rudolph B; Rehbein H; Staack A; Taupitz M; Prochnow D; Beyersdorff D
Invest Radiol; 2008 Jul; 43(7):481-7. PubMed ID: 18580330
[TBL] [Abstract][Full Text] [Related]
13. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results.
Kim CK; Park BK; Lee HM; Kwon GY
Invest Radiol; 2007 Dec; 42(12):842-7. PubMed ID: 18007156
[TBL] [Abstract][Full Text] [Related]
14. Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence.
Pucar D; Hricak H; Shukla-Dave A; Kuroiwa K; Drobnjak M; Eastham J; Scardino PT; Zelefsky MJ
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):62-9. PubMed ID: 17707266
[TBL] [Abstract][Full Text] [Related]
15. Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer.
Sciarra A; Panebianco V; Salciccia S; Osimani M; Lisi D; Ciccariello M; Passariello R; Di Silverio F; Gentile V
Eur Urol; 2008 Sep; 54(3):589-600. PubMed ID: 18226441
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI.
Langer DL; van der Kwast TH; Evans AJ; Trachtenberg J; Wilson BC; Haider MA
J Magn Reson Imaging; 2009 Aug; 30(2):327-34. PubMed ID: 19629981
[TBL] [Abstract][Full Text] [Related]
17. Tumor target volume for focal therapy of prostate cancer-does multiparametric magnetic resonance imaging allow for a reliable estimation?
Cornud F; Khoury G; Bouazza N; Beuvon F; Peyromaure M; Flam T; Zerbib M; Legmann P; Delongchamps NB
J Urol; 2014 May; 191(5):1272-9. PubMed ID: 24333516
[TBL] [Abstract][Full Text] [Related]
18. Value of endorectal MRI and MRS in patients with elevated prostate-specific antigen levels and previous negative biopsies to localize peripheral zone tumours.
Cirillo S; Petracchini M; Della Monica P; Gallo T; Tartaglia V; Vestita E; Ferrando U; Regge D
Clin Radiol; 2008 Aug; 63(8):871-9. PubMed ID: 18625351
[TBL] [Abstract][Full Text] [Related]
19. Diffusion tensor magnetic resonance imaging of prostate cancer.
Manenti G; Carlani M; Mancino S; Colangelo V; Di Roma M; Squillaci E; Simonetti G
Invest Radiol; 2007 Jun; 42(6):412-9. PubMed ID: 17507813
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of prostate cancer from normal prostate tissue in an animal model: conventional MRI and dynamic contrast-enhanced MRI.
Gemeinhardt O; Lüdemann L; Prochnow D; Abramjuk C; Taupitz M; Hamm B; Beyersdorff D
Rofo; 2005 Jul; 177(7):935-9. PubMed ID: 15973594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
